Biocompatible 3D printing materials are the ones capable of mimicking the natural tissue environment when implanted in the body without generating an immune response or should be non-toxic when in contact with the human body. Biocompatible 3D printing materials considered in this report are used in applications such as implants & prosthesis, tissue engineering, prototyping, hearing aids, and surgical tools and instruments. These biomaterials used in medical applications need to undergo several regulatory approvals to ensure that they are therapeutically safe. These materials are used in the form of powder, liquid, pellet, and filament. The biocompatible 3D printing materials market size is projected to grow from USD 308.1 million in 2018 to USD 832.7 million by 2023, at a CAGR of 22.0% between 2018 and 2023.
The key players operating in the biocompatible 3D printing materials market work on numerous projects to strengthen their market position. The major players operating in the biocompatible 3D printing materials market include 3D Systems, Inc. (US)., Evonik Industries AG (Germany), Stratasys Ltd. (US), Concept Laser, GmBH (Germany), EOS GmBH Electro Optical Systems (Germany), Renishaw PLC. (UK), Formlabs Inc. (US), EnvisionTEC, Inc. (Germany), 3D Composites (US), and Aspect Biosystems Ltd. (Canada). These companies have a strong presence in the biocompatible 3D printing materials market and are continuously undertaking efforts to improve their business strategies and product portfolios.
To know about the assumptions considered for the study download the pdf brochure
Evonik Industries AG is one of the prominent players in the global biocompatible 3D printing materials market. The company’s strong foothold in the market is primarily attributed to its focus on the product portfolio for various applications and strategic developments. This has also helped the company to register a positive brand image and gain a high share in the global biocompatible 3D printing materials market. For instance, in February 2018, the company has expanded its production capacity of high-performance polymer polyamide 12 for its VESTOSINT brand at its site in Marl Chemical Park in North Rhine-Westphalia. The expansion has helped the company to meet the demand for biocompatible 3D printing materials.
3D Systems, Inc. has established itself as one of the leading players in the global biocompatible 3D printing materials market with a wide distribution network globally. It provides end-to-end quality solutions for different medical applications such as medical implants, medical tools, dental prostheses, and surgical instruments among others. The company has a strong brand image, and it continues to expand its biocompatible 3D printing materials business by meeting the growing demand from consumers, globally. For instance, in February 2015, the company acquired Cimatron Ltd. (Israel). This acquisition has helped the company to integrate Cimatron’s software products into the company’s product portfolio. This development has enhanced the digital workflow between designing and additive manufacturing processes.
Biocompatible 3D Printing Materials Market by Type (Polymer, Metal), Application (Implants & Prosthesis, Prototyping & Surgical Guides, Tissue Engineering, Hearing Aid), Form (Powder, Liquid), and Region - Global Forecast to 2023
Mr. Shelly Singh
630 Dundee Road
Northbrook, IL 60062
USA : 1-888-600-6441
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.SEND ME A FREE SAMPLE